The invention relates to a
medicine for treating
ataxia hereditaria. The
medicine is prepared from the following medicinal raw materials in parts by weight: 18 parts of
uncaria rhynchophylla, 5 parts of fructus alpiniae oxyphyllae, 3 parts of fructus evodiae, 12 parts of Chinese wolfberry fruits, 12 parts of
astragalus membranaceus, 12 parts of
habenaria ciliolaris, 12 parts of radix scrophulariae and 6 parts of
fructus psoraleae. The
medicine applies
uncaria rhynchophylla with effects of clearing heat, soothing liver, calming endogenous wind and relieving spasm, fructus alpiniae oxyphyllae with effects of nourishing liver and kidneys and replenishing essence to benefit brain, fructus evodiae with effects of dispelling cold, relieving pain, soothing liver, depressing qi, warming middle-warmer and
drying dampness, Chinese wolfberry fruits with effects of nourishing liver and kidneys,
astragalus membranaceus with effects of tonifying
spleen and qi, nourishing kidneys and replenishing essence,
habenaria ciliolaris with effects of strengthening
low back and tonifying kidneys, radix scrophulariae with effects of clearing heat, cooling blood, nourishing yin and lowering internal heat, and
fructus psoraleae with effects of strengthening tendons and bones. The medicinal materials are combined to achieve the effects of tonifying kidneys and
spleen, warmly nourishing kidneys and Du meridians and strengthening tendons and bones. Clinical experiments prove that the medicine can be used for safely and effectively treating
ataxia hereditaria.